AEGiS-Reuters: AIDS Virus Treatments Up Heart Attack Risk -Study

Reuters, Ltd.Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


AIDS Virus Treatments Up Heart Attack Risk -Study

Reuters NewMedia - Wednesday November 19, 2003


BOSTON (Reuters) - The powerful drugs that beat back the AIDS virus may have a deadly drawback -- they may increase the risk of heart attack, according to a study in Thursday's New England Journal of Medicine.

However the findings may not be the final answer on whether the AIDS virus, HIV, or the drugs used to treat it, heighten the odds of heart problems.

Another study published in the Journal earlier this year suggested that heart disease rates were not higher among people taking the latest HIV treatments. Smaller studies had suggested that the risk was real.

The largest studies may have reached different conclusions because neither included a control group of uninfected people, said Peter Sklar and Henry Masur in an editorial in the Journal.

They suggested that the weight of the evidence seems to show that people who are taking the antiretroviral drugs now used to fight off HIV face a greater likelihood of heart attack. But the magnitude of that risk is still unknown.

"Antiretroviral therapies have been among the miracles of recent decades," they said. "Yet we must work toward mitigating the toxic effects that have the potential to diminish the quality and duration of patients' survival over the long term."

The study published on Wednesday found that the heart attack risk rose by 26 percent per year for people taking the drugs.

However, the rate of heart disease in that age group is relatively low to begin with.

Only 126 of the 23,468 patients had heart attacks over an 18-month period, according to the latest study, led by Jens Lundgren of Hvidovre University Hospital in Copenhagen.


031119
RE031118


Copyright © 2003 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .